{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:04:58Z","timestamp":1771869898565,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:00:00Z","timestamp":1337731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00198-012-2013-y","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T19:38:23Z","timestamp":1337715503000},"page":"697-705","source":"Crossref","is-referenced-by-count":30,"title":["Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures"],"prefix":"10.1007","volume":"24","author":[{"name":"on behalf of the Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lapi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Caputi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vaccheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Di Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Carle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Staniscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mazzaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,23]]},"reference":[{"key":"2013_CR1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"2013_CR2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"2013_CR3","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","volume":"21","author":"CA Migliorati","year":"2003","unstructured":"Migliorati CA (2003) Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 21:4253\u20134254","journal-title":"J Clin Oncol"},{"key":"2013_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0278-2391(09)01309-3","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J Oral Maxillofac Surg 67:2\u201312","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR6","first-page":"1391","volume":"35","author":"AA Khan","year":"2008","unstructured":"Khan AA, Sandor GK, Dore E et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35:1391\u20131397","journal-title":"J Rheumatol"},{"key":"2013_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","volume":"67","author":"LA Assael","year":"2009","unstructured":"Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35\u201343","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","volume":"15","author":"ME Sarasquete","year":"2009","unstructured":"Sarasquete ME, Gonzalez M, San Miguel JF, Garcia-Sanz R (2009) Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis 15:382\u2013387","journal-title":"Oral Dis"},{"key":"2013_CR11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2741\/e251","volume":"3","author":"F Marini","year":"2011","unstructured":"Marini F, Tonelli P, Cavalli L, Cavalli T, Masi L, Falchetti A, Brandi ML (2011) Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. Front Biosci (EliteEd) 3:364\u2013370","journal-title":"Front Biosci (EliteEd)"},{"key":"2013_CR12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.breast.2010.03.008","volume":"19","author":"V Fusco","year":"2010","unstructured":"Fusco V, Loidoris A, Colella G, Vescovi P, Campisi G (2010) Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment. Breast 19:432\u2013433","journal-title":"Breast"},{"key":"2013_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.oraloncology.2010.11.007","volume":"47","author":"P Vescovi","year":"2011","unstructured":"Vescovi P, Campisi G, Fusco V et al (2011) Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol 47:191\u2013194","journal-title":"Oral Oncol"},{"key":"2013_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR15","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","volume":"355","author":"JP Bilezikian","year":"2006","unstructured":"Bilezikian JP (2006) Osteonecrosis of the jaw\u2014do bisphosphonates pose a risk? N Engl J Med 355:2278\u20132281","journal-title":"N Engl J Med"},{"key":"2013_CR16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S1470-2045(08)70305-X","volume":"9","author":"BJ Edwards","year":"2008","unstructured":"Edwards BJ, Gounder M, McKoy JM et al (2008) Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol 9:1166\u20131172","journal-title":"Lancet Oncol"},{"key":"2013_CR17","first-page":"S113","volume":"22","author":"TI Jung","year":"2007","unstructured":"Jung TI, Hoffmeister B (2007) Osteonecrosis of jaw under bisphosphonate therapy: patient profile and risk assessment. J Bone Miner Res 22:S113\u2013S113","journal-title":"J Bone Miner Res"},{"key":"2013_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan FS, Gordon NP et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.joms.2006.02.011","volume":"64","author":"AI Zavras","year":"2006","unstructured":"Zavras AI, Zhu S (2006) Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis? J Oral Maxillofac Surg 64:917\u2013923","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00198-007-0502-1","volume":"19","author":"M Pazianas","year":"2008","unstructured":"Pazianas M, Blumentals W, Miller P (2008) Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int 19:773\u2013779","journal-title":"Osteoporos Int"},{"key":"2013_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro FA et al (2011) Risk factors for osteonecrosis of the jaws: a case\u2013control study from the CONDOR dental PBRN. J Dent Res 90:439\u2013444","journal-title":"J Dent Res"},{"key":"2013_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00228-009-0746-0","volume":"66","author":"HM Devold","year":"2010","unstructured":"Devold HM, Doung GM, Tverdal A, Furu K, Meyer HE, Falch JA, Sogaard AJ (2010) Prescription of anti-osteoporosis drugs during 2004\u20132007\u2014a nationwide register study in Norway. Eur J Clin Pharmacol 66:299\u2013306","journal-title":"Eur J Clin Pharmacol"},{"key":"2013_CR23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-009-1084-x","volume":"21","author":"P Piscitelli","year":"2009","unstructured":"Piscitelli P, Gimigliano F, Gatto S et al (2009) Hip fractures in Italy: 2000\u20132005 extension study. Osteoporos Int 21:1323\u20131330","journal-title":"Osteoporos Int"},{"key":"2013_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2011.09.048","volume":"50","author":"F Lapi","year":"2011","unstructured":"Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G (2011) Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone 50:85\u201390","journal-title":"Bone"},{"key":"2013_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MLR.0b013e3181808c05","volume":"47","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG (2009) Identification and validation of vertebral compression fractures using administrative claims data. Med Care 47:69\u201372","journal-title":"Med Care"},{"key":"2013_CR26","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-009-0840-2","volume":"20","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Taylor AJ, Matthews RS et al (2009) \"Pathologic\" fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporos Int 20:1969\u20131972","journal-title":"Osteoporos Int"},{"key":"2013_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jclinepi.2007.07.011","volume":"61","author":"PC Austin","year":"2008","unstructured":"Austin PC (2008) The performance of different propensity-score methods for estimating relative risks. J Clin Epidemiol 61:537\u2013545","journal-title":"J Clin Epidemiol"},{"key":"2013_CR28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pds.2098","volume":"20","author":"AR Patrick","year":"2011","unstructured":"Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Sturmer T (2011) The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf 20:551\u2013559","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2013_CR29","first-page":"691","volume":"35","author":"M Etminan","year":"2008","unstructured":"Etminan M, Aminzadeh K, Matthew IR, Brophy JM (2008) Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case\u2013control study. J Rheumatol 35:691\u2013695","journal-title":"J Rheumatol"},{"key":"2013_CR30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jclinepi.2003.12.017","volume":"57","author":"AB Beiderbeck","year":"2004","unstructured":"Beiderbeck AB, Sturkenboom MC, Coebergh JW, Leufkens HG, Stricker BH (2004) Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up. J Clin Epidemiol 57:973\u2013977","journal-title":"J Clin Epidemiol"},{"key":"2013_CR31","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","volume":"68","author":"S Otto","year":"2010","unstructured":"Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Schieker M (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837\u20132845","journal-title":"J Oral Maxillofac Surg"},{"key":"2013_CR32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","volume":"86","author":"DB Kimmel","year":"2007","unstructured":"Kimmel DB (2007) Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 86:1022\u20131033","journal-title":"J Dent Res"},{"key":"2013_CR33","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","volume":"83","author":"DE Hughes","year":"1989","unstructured":"Hughes DE, MacDonald BR, Russell RG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930\u20131935","journal-title":"J Clin Invest"},{"key":"2013_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.critrevonc.2007.07.005","volume":"64","author":"IJ Diel","year":"2007","unstructured":"Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, Vaananen K, Pylkkanen L, Pecherstorfer M, Aapro MS (2007) Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates? Crit Rev Oncol Hematol 64:198\u2013207","journal-title":"Crit Rev Oncol Hematol"},{"key":"2013_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2007.10.020","volume":"42","author":"PD Delmas","year":"2008","unstructured":"Delmas PD, Siris ES (2008) NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women. Bone 42:16\u201318","journal-title":"Bone"},{"key":"2013_CR36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2013-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2013-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:46Z","timestamp":1558624126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,23]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2013-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,23]]}}}